Pentixapharm Holding AG (XTER:PTP) FFO


XTER:PTP Pentixapharm Holding AG XTER:PTP
12 GF Score
Price €2.10
! 2 Warning Signs
View Full Analysis

What is Pentixapharm Holding AG FFO?

FFO (Funds from operations) only applies to REITs.

XTER:PTP
12GF Score
Pentixapharm Holding AG XTER:PTP
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pentixapharm Holding AG Business Description

Other Exchanges PTPN:Austria
Address Robert-Rossle-Street 10, Berlin, DEU, 13125
Pentixapharm Holding AG is a clinical-stage biopharmaceutical company active in the field of research and development of radiopharmaceuticals for diagnostic and therapeutic applications. Radiopharmaceuticals are medical substances containing radioactive elements used in nuclear medicine to diagnose or treat diseases. Its clinical pipeline encompasses PentixaTher, a Yttrium-90 based therapeutic against non-Hodgkin lymphomas (NHL), and PentixaFor, a Gallium-68-based companion diagnostic. Its Pipeline products include: Pentixa Ther, PT-002, PentixaFor, PT-001, PentixaFor, PT-001, PT-00X, GT-001, GT-002, GT-005, GT-008, and GT-00X.
12GF Score

Get the complete analysis for XTER:PTP

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.10
Price